Predictors and optimal management of tumor necrosis factor antagonist nonresponse in inflammatory bowel disease: A literature review

doi:10.3748/wjg.v29.i29.4481

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 29, Issue 29

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6033)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

116

WORD

HTML

3357

Figures (1-2)

355

Tables (1-2)

620

Sum=4492

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

148

Download

535

Sum=683

Publishing Process of This Article

Item

Count

Browse

146

Download

444

Sum=590

Aug 7, 2023 (publication date) through Jan 11, 2025

Times Cited of This Article

Times Cited (7)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Aug 7, 2023; 29(29): 4481-4498
Published online Aug 7, 2023. doi: 10.3748/wjg.v29.i29.4481

Open in New Tab Full Size Figure Download Figure

Figure 1 Flow diagram for management of primary nonresponse to tumor necrosis factor antagonists. PNR: Primary nonresponse; TNF: Tumor necrosis factor; TL: Trough level; ADA: Antidrug antibody.

Open in New Tab Full Size Figure Download Figure

Figure 2 Flow diagram for management of secondary nonresponse to tumor necrosis factor antagonists. SNR: Secondary nonresponse; TNF: Tumor necrosis factor; TL: Trough level; ADA: Antidrug antibody.

Citation: Wang LF, Chen PR, He SK, Duan SH, Zhang Y. Predictors and optimal management of tumor necrosis factor antagonist nonresponse in inflammatory bowel disease: A literature review. World J Gastroenterol 2023; 29(29): 4481-4498
URL: https://www.wjgnet.com/1007-9327/full/v29/i29/4481.htm
DOI: https://dx.doi.org/10.3748/wjg.v29.i29.4481